Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease

Paricalcitol, a selective vitamin D receptor (VDR) activator used for treatment of secondary hyperparathyroidism in chronic kidney disease (CKD), has been associated with survival advantages, suggesting that this drug, beyond its ability to suppress parathyroid hormone, may have additional beneficia...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Donate-Correa, J., Domínguez-Pimentel, V., Méndez-Pérez, M. L., Muros-de-Fuentes, M., Mora-Fernández, C., Martín-Núñez, E., Cazaña-Pérez, V., Navarro-González, J. F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913352/
https://ncbi.nlm.nih.gov/pubmed/24511210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/670475
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky